SCHEMBL1776266

SCHEMBL1776266

O=C1CCCN1c1ccc(OCCN2CCCC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 3/20 0.59
▸ LTA4H P09960 4/20 0.55
▸ PTGS1 P23219 1/20 0.55
▸ PTGS2 P35354 1/20 0.55
▸ PSMB1 P20618 2/20 0.54
▸ PSMB5 P28074 2/20 0.54
▸ PSMB2 P49721 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.53
▸ MAPK14 Q16539 1/20 0.53
▸ LMNA P02545 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ PKM P14618 1/20 0.53
▸ HRH3 Q9Y5N1 4/20 0.52
▸ MCHR1 Q99705 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.51
▸ KCNH2 Q12809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22065525 0.88 KDM1A (0.62) KDM1ALTA4HPTGS1PTGS2ALDH1A1
SCHEMBL19048030 0.86 KDM1A (0.62) KDM1AHRH3KDM4E
SCHEMBL19091484 0.82 KDM1A (0.62) KDM1ALTA4HPTGS1PTGS2PSMB1
SCHEMBL1777745 0.81 ADRA1B (0.58) KDM1AALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL1180431 0.80 HRH3 (0.49) MAPK14HRH3KCNH2
SCHEMBL6552462 0.79 LMNA (0.61) ALDH1A1LMNAHTTSMN1; SMN2PKM
SCHEMBL15518712 0.78 HTR2C (0.61) MCHR1
SCHEMBL25317997 0.78 OPRL1 (0.51) KDM1ALTA4HALDH1A1LMNAHTT
SCHEMBL11307872 0.77 PSMB1 (0.50) LTA4HPTGS1PTGS2PSMB1PSMB5
SCHEMBL1777134 0.76 HRH3 (0.57) HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 — — US claimed
EP-1943217-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2008-07-16 — — EP claimed
WO-2007048595-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA, S.A. (BE) 2007-05-03 — — WO claimed
US-7943605-B2 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses UCB PHARMA S.A. (BE) 2011-05-17 — — US disclosed
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 — — US disclosed
EP-1943217-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2008-07-16 — — EP disclosed
WO-2007048595-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA, S.A. (BE) 2007-05-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses COASY, FURIN, PEPD KDM1A 3473/4885LTA4H 398/4885PTGS1 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback